News
During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...
The vascular parkinsonism market is forecasted to grow from USD 319.5 million in 2025 to USD 538.1 million by 2035, at a CAGR of 6.20% during the forecast period. The growth is being driven by the ...
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
“Declining gait speed may signal early cognitive decline and structural brain ageing,” he said. “It can help detect ...
Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and ...
The modern boxing comeback is a perfect storm where the fighter’s timeless need for purpose has collided with an economy that ...
July 10, 2025 Stephen Braun, 65 of Winnipeg formerly of Altona passed away Tuesday, July 1st in Winnipeg. He is survived by ...
About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...
22d
MedPage Today on MSNCAR-T for Multiple Myeloma: How to Choose Between Therapies?CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or refractory multiple myeloma. In 2021, the FDA approved idecabtagene vicleucel (ide ...
KATHMANDU, July 9: The citizens enrolled in the health insurance program would receive upto Rs 200,000 for their health care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results